416. Enhanced GBM Therapy Using a New Class of HSV Oncolytic Vector

Molecular Therapy - United States
doi 10.1016/s1525-0016(16)34751-7
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Elsevier BV

Related search

520. Arming a Tumor Targeted Oncolytic HSV Vector With MMP9 for Enhanced Distribution and Killing Activity

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2016English

Systemic Oncolytic Cytokine HSV Therapy of Prostate Cancer

2007English

A Fully Replication-Competent Adenovirus Vector With Enhanced Oncolytic Properties

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2010English

A Fully-Virulent Retargeted Oncolytic HSV Armed With IL-12 Elicits Local Immunity and Vaccine Therapy Towards Distant Tumors

PLoS Pathogens
ImmunologyMolecular BiologyVirologyMicrobiologyParasitologyGenetics
2018English

Oncolytic Adenoviral Vector Carrying the Cytosine Deaminase Gene for Melanoma Gene Therapy

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2006English

Oncolytic HSV-1 Virotherapy: Clinical Experience and Opportunities for Progress

Current Pharmaceutical Biotechnology
BiotechnologyPharmaceutical Science
2012English

Oncolytic Vaccinia Virus as a Vector for Therapeutic Sodium Iodide Symporter Gene Therapy in Prostate Cancer

Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2016English

New Gene Therapy Vector—Nano-Hydroxyapatite

Material Sciences
2013English

HSV Vector Cytotoxicity Is Inversely Correlated With Effective TK/GCV Suicide Gene Therapy of Rat Gliosarcoma

Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2000English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy